Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy

Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy

Abstract Background Retinopathy of prematurity (ROP) remains a major cause of childhood blindness and current laser photocoagulation and anti-VEGF antibody treatments are associated with reduced peripheral vision and possible delayed development of retinal vasculatures and neurons. In this study, we...

Full description

Bibliographic Details
Main Authors: Rong Zhou, Shuya Zhang, Xuejiao Gu, Yuanyuan Ge, Dingjuan Zhong, Yuling Zhou, Lingyun Tang, Xiao-Ling Liu, Jiang-Fan Chen
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Molecular Medicine
Subjects:
Retinopathy of prematurity
Oxygen-induced retinopathy
Adenosine A2A receptor
KW6002
Online Access:http://link.springer.com/article/10.1186/s10020-018-0038-1

Internet

http://link.springer.com/article/10.1186/s10020-018-0038-1

Similar Items